Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT03134638
Title A Study of SY-1365 in Adult Patients With Advanced Solid Tumors
Recruitment Terminated
Gender both
Phase Phase I
Variant Requirements No
Sponsors Syros Pharmaceuticals
Indications

Advanced Solid Tumor

fallopian tube cancer

peritoneal carcinoma

Her2-receptor negative breast cancer

ovarian clear cell carcinoma

ovarian serous carcinoma

Therapies

Carboplatin + SY-1365

SY-1365

Fulvestrant + SY-1365

Age Groups: adult | senior
Covered Countries USA | CAN

Facility Status City State Zip Country Details
University of Alabama at Birmingham Birmingham Alabama 35233 United States Details
Honor Health Research Institute Scottsdale Arizona 85258 United States Details
Palo Alto Medical Foundation Group San Francisco California 94118 United States Details
University of Chicago Medical Center Chicago Illinois 60637 United States Details
Massachusetts General Hospital Boston Massachusetts 02114 United States Details
Dana Farber Cancer Institute Boston Massachusetts 02215 United States Details
Columbia University Medical Center New York New York 10032 United States Details
Stephenson Cancer Center Oklahoma City Oklahoma 73104 United States Details
Willamette Valley Cancer Institute and Research Center Eugene Oregon 97401 United States Details
Women and Infants Hospital of Rhode Island Providence Rhode Island 02905 United States Details
Tennessee Oncology Nashville Tennessee 37203 United States Details
Texas Oncology Austin Texas 78705 United States Details
University of Texas Southwestern Medical Center Dallas Texas 75390 United States Details
Texas Oncology Fort Worth Texas 76104 United States Details
South Texas Accelerated Research Therapeutics San Antonio Texas 78229 United States Details
Hamilton Health Sciences Hamilton Ontario L8V 1C3 Canada Details
McGill University Health Center Montréal Quebec H4A 3J1 Canada Details
Centre Léon Bérard Lyon 69373 Lyon Cedex France Details
Institut de Cancérologie de l'Ouest Saint-Herblain 44805 Saint Herblain Cedex France Details
Institut Gustave Roussy Villejuif 94805 Villejuif Cedex France Details
*Shaded cells indicate that there was no data available from clincialtrials.gov for the field